Skip to content
10-Q

Quarterly Report

AIFARM, LTD.

0001654954-19-006307

← back to feed
Filed
May 20, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 20, 2019 0 sh
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$133.16K
Operating Cash Flow restated Q1 2019 · Mar 31, 2018 −$93.53K
Stockholders Equity Q1 2019 · Mar 31, 2019 −$1.9M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$1.95M
Total Liabilities Q1 2019 · Mar 31, 2019 $3.59M
Total Liabilities Q1 2019 · Dec 31, 2018 $3.59M
Total Assets Q1 2019 · Mar 31, 2019 $146.28K
Total Assets Q1 2019 · Dec 31, 2018 $97.12K
Sga Expense Q1 2019 · Mar 31, 2019 $135.35K
Sga Expense restated Q1 2019 · Mar 31, 2018 $35.07K
Net Income Q1 2019 · Mar 31, 2019 −$135.35K
Net Income Q1 2019 · Mar 31, 2018 −$35.07K